company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q1,2013-01-01,2013-03-31,2014-06-20 17:00:38+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4599000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q1,2013-01-01,2013-03-31,2014-06-20 17:00:38+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4599000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q1,2013-01-01,2013-03-31,2014-06-20 17:00:38+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4599000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q1,2013-01-01,2013-03-31,2014-06-20 17:00:38+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1821000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q1,2013-01-01,2013-03-31,2014-06-20 17:00:38+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8482000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q1,2013-01-01,2013-03-31,2014-06-20 17:00:38+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10303000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q1,2013-01-01,2013-03-31,2014-06-20 17:00:38+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5704000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q1,2013-01-01,2013-03-31,2014-06-20 17:00:38+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,22000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q1,2013-01-01,2013-03-31,2014-06-20 17:00:38+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,22000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q1,2013-01-01,2013-03-31,2014-06-20 17:00:38+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5682000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q1,2013-01-01,2013-03-31,2014-06-20 17:00:38+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5682000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q1,2013-01-01,2013-03-31,2014-06-20 17:00:38+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5682000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q1,2013-01-01,2013-03-31,2014-06-20 17:00:38+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5682000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q1,2013-01-01,2013-03-31,2014-06-20 17:00:38+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1000000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q1,2013-01-01,2013-03-31,2014-06-20 17:00:38+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-5.89
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q1,2013-01-01,2013-03-31,2014-06-20 17:00:38+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1000000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q1,2013-01-01,2013-03-31,2014-06-20 17:00:38+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-5.89
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q1,2013-01-01,2013-03-31,2014-06-20 17:00:38+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,964572.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q1,2013-01-01,2013-03-31,2014-06-20 17:00:38+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-5.89
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:39:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4663000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:39:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4663000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:39:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4663000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:39:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1641000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:39:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8145000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:39:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9786000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:39:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5123000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:39:12+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,16000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:39:12+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-40000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:39:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-24000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:39:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5147000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:39:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5147000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:39:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5147000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:39:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5147000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:39:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1000000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:39:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-5.27
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:39:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1000000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:39:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-5.27
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:39:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,976584.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:39:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-5.27
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 16:16:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4710000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 16:16:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4710000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 16:16:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4710000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 16:16:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1859000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 16:16:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8922000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 16:16:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10781000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 16:16:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6071000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 16:16:16+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,9000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 16:16:16+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,153000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 16:16:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,162000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 16:16:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5909000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 16:16:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5909000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 16:16:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5909000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 16:16:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5909000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 16:16:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,976584.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 16:16:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-6.05
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 16:16:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,976584.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 16:16:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-6.05
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 16:16:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1000000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 16:16:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-6.05
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4824000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4824000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4824000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2353000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6334000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8687000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3863000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,7000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-19000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-12000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3875000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3875000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3875000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3875000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,975158.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-3.93
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,975158.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-3.93
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1000000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-3.93
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q1,2014-01-01,2014-03-31,2014-06-20 17:00:38+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4782000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q1,2014-01-01,2014-03-31,2014-06-20 17:00:38+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4782000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q1,2014-01-01,2014-03-31,2014-06-20 17:00:38+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4782000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q1,2014-01-01,2014-03-31,2014-06-20 17:00:38+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3160000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q1,2014-01-01,2014-03-31,2014-06-20 17:00:38+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7020000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q1,2014-01-01,2014-03-31,2014-06-20 17:00:38+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10180000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q1,2014-01-01,2014-03-31,2014-06-20 17:00:38+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5398000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q1,2014-01-01,2014-03-31,2014-06-20 17:00:38+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q1,2014-01-01,2014-03-31,2014-06-20 17:00:38+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q1,2014-01-01,2014-03-31,2014-06-20 17:00:38+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5395000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q1,2014-01-01,2014-03-31,2014-06-20 17:00:38+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5395000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q1,2014-01-01,2014-03-31,2014-06-20 17:00:38+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5395000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q1,2014-01-01,2014-03-31,2014-06-20 17:00:38+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5395000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q1,2014-01-01,2014-03-31,2014-06-20 17:00:38+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1000000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q1,2014-01-01,2014-03-31,2014-06-20 17:00:38+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-5.38
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q1,2014-01-01,2014-03-31,2014-06-20 17:00:38+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1000000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q1,2014-01-01,2014-03-31,2014-06-20 17:00:38+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-5.38
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q1,2014-01-01,2014-03-31,2014-06-20 17:00:38+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1002220.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q1,2014-01-01,2014-03-31,2014-06-20 17:00:38+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-5.38
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:11:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4703000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:11:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4703000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:11:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4703000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:11:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2736000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:11:58+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9377000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:11:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12113000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:11:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7410000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:11:58+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,9000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:11:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,9000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:11:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7401000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:11:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7401000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:11:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7401000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:11:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7401000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:11:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,18500000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:11:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.4
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:11:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,18500000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:11:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.4
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:11:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,18556561.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:11:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.4
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:37:11+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,38784000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:37:11+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,38784000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:37:11+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,38784000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:37:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3158000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:37:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7047000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:37:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10205000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:37:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,28579000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:37:11+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,18000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:37:11+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,49000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:37:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,67000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:37:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,28646000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:37:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,28646000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:37:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,28646000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:37:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,28646000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:37:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,30805163.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:37:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.93
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:37:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,32513113.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:37:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.88
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:37:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30800000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:37:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.93
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6436000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6436000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6436000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3408000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9995000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13403000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6967000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,14000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,11000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,25000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6942000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6942000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6942000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6942000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,20506565.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,5.28
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29427287.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,5.2
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,20700000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.28
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:02:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3677000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:02:33+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11035000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:02:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14712000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:02:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14712000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:02:33+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,59000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:02:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,59000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:02:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14653000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:02:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14653000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:02:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14653000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:02:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14653000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:02:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,36600000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:02:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.4
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:02:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36600000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:02:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.4
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:02:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,36903483.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:02:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.4
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q2,2015-04-01,2015-06-30,2016-07-26 16:01:05+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3930000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q2,2015-04-01,2015-06-30,2016-07-26 16:01:05+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14088000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q2,2015-04-01,2015-06-30,2016-07-26 16:01:05+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18018000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q2,2015-04-01,2015-06-30,2016-07-26 16:01:05+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-18018000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q2,2015-04-01,2015-06-30,2016-07-26 16:01:05+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,74000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q2,2015-04-01,2015-06-30,2016-07-26 16:01:05+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,289000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q2,2015-04-01,2015-06-30,2016-07-26 16:01:05+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,363000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q2,2015-04-01,2015-06-30,2016-07-26 16:01:05+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17655000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q2,2015-04-01,2015-06-30,2016-07-26 16:01:05+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17655000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q2,2015-04-01,2015-06-30,2016-07-26 16:01:05+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17655000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q2,2015-04-01,2015-06-30,2016-07-26 16:01:05+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17655000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q2,2015-04-01,2015-06-30,2016-07-26 16:01:05+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38400000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q2,2015-04-01,2015-06-30,2016-07-26 16:01:05+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.46
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q2,2015-04-01,2015-06-30,2016-07-26 16:01:05+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,38400000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q2,2015-04-01,2015-06-30,2016-07-26 16:01:05+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.46
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q2,2015-04-01,2015-06-30,2016-07-26 16:01:05+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,38162226.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q2,2015-04-01,2015-06-30,2016-07-26 16:01:05+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.46
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 16:01:39+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4318000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 16:01:39+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,22852000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 16:01:39+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27170000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 16:01:39+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-27170000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 16:01:39+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,248000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 16:01:39+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-75000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 16:01:39+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,173000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 16:01:39+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-26997000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 16:01:39+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26997000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 16:01:39+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-26997000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 16:01:39+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-26997000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 16:01:39+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43500000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 16:01:39+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.62
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 16:01:39+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,43500000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 16:01:39+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.62
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 16:01:39+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43525888.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 16:01:39+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.62
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4793000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21636000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26429000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-26429000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,321000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-57000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,264000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-26165000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26165000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-26165000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-26165000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,40500000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.63
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,40500000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.63
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,40586980.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.63
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:01:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6045000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:01:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,27647000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:01:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,33692000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:01:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-33692000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:01:53+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,415000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:01:53+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-86000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:01:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,329000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:01:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-33363000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:01:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-33363000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:01:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-33363000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:01:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-33363000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:01:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43900000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:01:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.76
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:01:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,43900000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:01:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.76
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:01:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43753517.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:01:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.76
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:01:09+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,113000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:01:09+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,113000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:01:09+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,113000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:01:09+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,113000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:01:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6466000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:01:09+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,33833000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:01:09+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-1050000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:01:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,39249000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:01:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-39249000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:01:09+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,529000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:01:09+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-146000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:01:09+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,383000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:01:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-38866000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:01:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-38866000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:01:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-38866000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:01:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-38866000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:01:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,49200000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:01:09+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.79
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:01:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49200000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:01:09+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.79
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:01:09+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,49284573.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:01:09+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.79
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:19:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6239000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:19:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,29491000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:19:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,35730000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:19:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-35730000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:19:28+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,549000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:19:28+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,141000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:19:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,690000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:19:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-35040000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:19:28+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-94000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:19:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-35134000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:19:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-35134000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:19:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-35134000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:19:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,50200000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:19:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.7
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:19:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,50200000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:19:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.7
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:19:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,50226588.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:19:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.7
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,-113000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,-113000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,113000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7511000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,41789000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,49300000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-49187000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,473000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-86000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,387000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-48800000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-91000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-48891000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-48891000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-48891000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,48400000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.98
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,48400000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.98
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,48407565.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.98
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9981000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,90689000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,100670000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-100670000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:48+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:48+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,485000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:48+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,6000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,491000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-100179000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:48+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-149000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-100328000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-100328000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:48+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-100328000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,50400000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.99
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,50400000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.99
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,50395632.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.99
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:01:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,683000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:01:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,683000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:01:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,683000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:01:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10231000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:01:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,65276000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:01:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,75507000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:01:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-74824000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:01:44+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:01:44+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,438000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:01:44+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-113000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:01:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,325000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:01:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-74499000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:01:44+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-130000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:01:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-74629000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:01:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-74629000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:01:44+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:01:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-74629000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:01:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,50400000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:01:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.48
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:01:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,50400000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:01:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.48
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:01:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,50427865.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:01:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.48
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:06:36+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8236000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:06:36+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,52188000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:06:36+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,60424000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:06:36+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-60424000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:06:36+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,763000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:06:36+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,280000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:06:36+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1043000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:06:36+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-59381000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:06:36+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-184000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:06:36+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-59565000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:06:36+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-59565000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:06:36+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-59565000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:06:36+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,64700000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:06:36+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.92
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:06:36+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,64700000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:06:36+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.92
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:06:36+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,64526519.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:06:36+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.92
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,936000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,936000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,936000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11273000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,44749000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,56022000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-55086000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,809000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,100000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,909000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-54177000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-180000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-54357000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-54357000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-54357000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,58400000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.56
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,58400000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.56
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,58347284.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.56
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:01:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:01:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11662000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:01:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,74048000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:01:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,85710000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:01:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-85710000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:01:48+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2851000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:01:48+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1643000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:01:48+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,109000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:01:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1099000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:01:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-86809000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:01:48+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-222000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:01:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-87031000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:01:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-87031000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:01:48+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,30543000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:01:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-117574000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:01:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,68000000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:01:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.73
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:01:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,68000000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:01:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.73
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:01:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,67844872.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:01:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.73
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 16:01:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 16:01:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12154000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 16:01:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,52818000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 16:01:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,64972000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 16:01:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-64972000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 16:01:44+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4688000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 16:01:44+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2533000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 16:01:44+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1262000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 16:01:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3417000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 16:01:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-68389000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 16:01:44+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,0.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 16:01:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-68389000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 16:01:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-68389000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 16:01:44+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,2302000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 16:01:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-70691000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 16:01:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,68000000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 16:01:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.04
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 16:01:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,68000000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 16:01:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.04
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 16:01:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,67966066.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 16:01:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.04
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 16:06:36+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 16:06:36+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10685000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 16:06:36+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,47793000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 16:06:36+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,58478000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 16:06:36+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-58478000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 16:06:36+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4783000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 16:06:36+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2458000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 16:06:36+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-117000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 16:06:36+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2442000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 16:06:36+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-60920000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 16:06:36+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-60920000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 16:06:36+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-60920000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 16:06:36+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,1279000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 16:06:36+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-62199000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 16:06:36+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,68400000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 16:06:36+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.91
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 16:06:36+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,68400000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 16:06:36+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.91
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 16:06:36+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,68232765.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 16:06:36+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.91
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12973000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,64449000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,77422000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-77422000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4863000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2275000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-79000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2667000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-80089000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-80089000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-80089000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,1381000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-81470000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,68200000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.19
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,68200000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.19
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,68099105.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.19
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:07:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:07:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,44498000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:07:13+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,69589000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:07:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,114087000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:07:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-114087000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:07:13+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4838000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:07:13+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1966000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:07:13+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-975000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:07:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3847000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:07:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-117934000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:07:13+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,0.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:07:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-117934000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:07:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-117934000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:07:13+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,1311000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:07:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-119245000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:07:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73200000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:07:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.63
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:07:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,73200000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:07:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.63
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:07:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73056907.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:07:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.63
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:02:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:02:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,21633000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:02:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,34125000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:02:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,55758000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:02:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-55758000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:02:01+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4975000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:02:01+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2492000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:02:01+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-170000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:02:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2653000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:02:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-58411000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:02:01+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,0.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:02:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-58411000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:02:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-58411000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:02:01+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,1480000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:02:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-59891000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:02:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,83200000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:02:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.72
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:02:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,83200000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:02:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.72
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:02:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,83479867.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:02:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.72
